The Avon Foundation for Women has awarded the Clemson University Institute for Biological Interfaces of Engineering a $195,000 grant to support research to develop new ways to improve reconstructive breast surgery using engineered tissue that contains anti-cancer properties. "We're working on an injectable cell-based biomaterial that will be designed to reduce tumor recurrence," said Karen Burg, institute director and Hunter Endowed Chair of Bioengineering.